DS
Therapeutic Areas
SiSaf Pipeline
| Drug | Indication | Phase |
|---|---|---|
| miRNA-based therapy | Pancreatic Ductal Adenocarcinoma (Solid Tumors) | Pre-clinical |
| siRNA-based therapy | Metastatic Cancer | Pre-clinical |
| SiS-ADO2 (siRNA) | Autosomal Dominant Osteopetrosis Type II (ADO2) | Pre-clinical |